|
|
|
| Laparoscopic distal pancreatectomy with or without splenectomy: spleen-preservation does not increase morbidity |
| Yu-Pei Zhao, Xiao Du, Meng-Hua Dai, Tai-Ping Zhang, Quan Liao, Jun-Chao Guo, Lin Cong and Ge Chen |
Beijing, China
Author Affiliations: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China (Zhao YP, Du X, Dai MH, Zhang TP, Liao Q, Guo JC, Cong L and Chen G)
Corresponding Author: Yu-Pei Zhao, MD, Department of General Surgery, Peking Union Medical College Hospital, No. 1, Shuai Fu Yuan, Beijing 100730, China (Tel: 86-10-65296007; Fax: 86-10-65124875; Email: zhao8028@263.net) |
|
|
|
|
Abstract BACKGROUND: The indications for laparoscopic spleen-preserving distal pancreatectomy (LSPDP) and its morbidity compared with laparoscopic distal pancreatectomy with splenectomy (LDPS) are ill-defined. This study aimed to share the indications for spleen-preservation and investigate the safety and outcome of LSPDP at our institution.
METHODS: A retrospective review of patients who were scheduled to receive laparoscopic surgery for distal pancreatic lesions was conducted. The indications, surgical procedures, intra-operative data, and outcomes of the two procedures were collected and compared by statistical analysis.
RESULTS: LDPS and LSPDP were successfully performed in 16 and 21 patients respectively, whereas they were converted to open surgery in 9 patients. There were no significant differences in age, gender, operation time, blood loss, and conversion rate between the LDPS and LSPDP groups. The mean tumor size showed an inter-group difference (5.05 vs 2.53 cm, P<0.001). There were no significant differences in complication and morbidity rates between the two groups. All patients remained alive without recurrence during a follow-up of 9 to 67 months (median 35).
CONCLUSION: LSPDP has a morbidity and outcome comparable to LDPS.
|
|
|
|
|
|
|
|
|
2012, Vol. 11 
